Progyny News

Progyny (NASDAQ:PGNY) Has More To Do To Multiply In Value Going Forward

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongsi

Simply Wall StJun 18 15:23 ET

Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth

PRNewswireJun 11 11:00 ET

Express News | Progyny Outlook FY Revenue USD 225-250 Million

ReutersJun 11 11:00 ET

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive

GlobeNewswireJun 4 15:00 ET

Progyny's (NASDAQ:PGNY) Performance Is Even Better Than Its Earnings Suggest

Investors were underwhelmed by the solid earnings posted by Progyny, Inc. (NASDAQ:PGNY) recently. We did some digging and actually think they are being unnecessarily pessimistic. NasdaqGS:PGNY Ear

Simply Wall StMay 23 08:49 ET

Progyny:Bd of Directors Approved Shr Repurchase Up to $100M of Common Stk, Follows Program Announced Feb 29 >PGNY

Progyny:Bd of Directors Approved Shr Repurchase Up to $100M of Common Stk, Follows Program Announced Feb 29 >PGNY

Dow JonesMay 22 17:01 ET

Express News | Progyny Announces $100M Share Repurchase Program Approved By Board Of Directors; To Be Funded Through Available Cash Balances

BenzingaMay 22 17:00 ET

Express News | Progyny Announces $100M Stock Repurchase Program

ReutersMay 22 17:00 ET

Express News | Progyny Inc - Approved a Share Repurchase Program to Repurchase up to $100 Mln of Its Common Stock

ReutersMay 22 17:00 ET

Express News | Progyny, Inc. Announces Additional Share Repurchase Program

ReutersMay 22 17:00 ET

Analysts Are Bullish on Top Healthcare Stocks: Progyny (PGNY), Regeneron (REGN)

TipRanksMay 21 08:11 ET

Barclays Sticks to Its Buy Rating for Progyny (PGNY)

TipRanksMay 20 05:50 ET

Progyny Is Maintained at Buy by Truist Securities

Progyny Is Maintained at Buy by Truist Securities

Dow JonesMay 17 08:37 ET

Express News | Progyny Inc : Truist Securities Cuts Target Price to $37.00 From $46.00

ReutersMay 17 07:12 ET

Truist Securities Cuts Price Target on Progyny to $37 From $46, Keeps Buy Rating

Progyny (PGNY) has an average rating of buy and price targets ranging from $30 to $48, according to analysts polled by Capital IQ. Price: 27.15, Change: -0.40, Percent Change: -1.45

MT NewswiresMay 17 05:27 ET

Progyny Price Target Maintained With a $48.00/Share by Cantor Fitzgerald

Progyny Price Target Maintained With a $48.00/Share by Cantor Fitzgerald

Dow JonesMay 16 13:43 ET

Express News | Cantor Fitzgerald Reiterates Overweight on Progyny, Maintains $48 Price Target

BenzingaMay 16 13:32 ET

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Arvinas Holding Company (ARVN) and Progyny (PGNY)

TipRanksMay 16 12:40 ET

Express News | Progyny Inc : JP Morgan Cuts Target Price to $41 From $51

ReutersMay 15 00:32 ET

Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Progyny's executives will participate in a

GlobeNewswireMay 14 11:00 ET